| Comparison of high-dose bolus tirofiban versus abciximab as adjunctive therapy for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: A meta-analysis of randomized trials | |
| Dong L., Zhang F., Shu X. | |
| 刊名 | Journal of the American College of Cardiology
 |
| 2010 | |
| 卷号 | 55 |
| ISSN号 | 0735-1097 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4929463 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Dong L., Zhang F., Shu X.. Comparison of high-dose bolus tirofiban versus abciximab as adjunctive therapy for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: A meta-analysis of randomized trials[J]. Journal of the American College of Cardiology,2010,55. |
| APA | Dong L., Zhang F., Shu X..(2010).Comparison of high-dose bolus tirofiban versus abciximab as adjunctive therapy for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: A meta-analysis of randomized trials.Journal of the American College of Cardiology,55. |
| MLA | Dong L., Zhang F., Shu X.."Comparison of high-dose bolus tirofiban versus abciximab as adjunctive therapy for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: A meta-analysis of randomized trials".Journal of the American College of Cardiology 55(2010). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论